Methylmalonic acid and total homtxystcinc in plasma and serum havc previously hccn uscd as indicators of intraccllular cobalamin function in adults. To assess the usefulness o f quantitation of thcsc mct;iholitcs in the diagnosis o f tlict;lry cc)balamin ddicicncy in infants, they were dctcrniinccl in plasma from 41 infilnts (;rgcd I(L20 nio) on ;I niilcrohiotic diet and in 5 0 healthy group-matched oninivorous controls. In the macrobiotic infilnts. hoth nicthylmalonic acid and total homocystcinc were markedly increased compared with controls (8-fold and 2-fold, respectively). Both mcti~holitcs showed ;III inverse relation t o the pli~smir cohalamin Icvcl. The very low cobalamin content of the miicrohiotic diet and low pl;lsniir cobalamin in milcrobiotic inl'ilnts m;~kcs ;in inip;~ircd coh;llamin function likely in thcsc infants. Wc thcrclorc uscd dictary group os ;In indcpcndcnt indicator of coh;llamiri status. Different tcst pilrilnictcrs for cohalaniin st;~tus wcrc evaluated hy comparing their ahility t o discriniiri;rtc hetween the two dietary groups. Logistic rcgrcssion irnalysis showed that methylmalonic acid followed by total homo-T h e h u m a n requirement for cobalamin is usually c o ve r e d b y food of animal origin (I). Nutritional cob;llamin dcticiency may, however, develop in strict vcgct;lrians (1, 2). O f particular c o n c e r n a r e several reports o n s c v c r c cobalamin deticiency in infants born t o vegetarian mothe r s (2-6). Neurologic disorders h a v c h c c n o b s e r v e d in s u c h infants (7).
Methylmalonic acid and total homtxystcinc in plasma and serum havc previously hccn uscd as indicators of intraccllular cobalamin function in adults. To assess the usefulness o f quantitation of thcsc mct;iholitcs in the diagnosis o f tlict;lry cc)balamin ddicicncy in infants, they were dctcrniinccl in plasma from 41 infilnts (;rgcd I(L20 nio) on ;I niilcrohiotic diet and in 5 0 healthy group-matched oninivorous controls. In the macrobiotic infilnts. hoth nicthylmalonic acid and total homocystcinc were markedly increased compared with controls (8-fold and 2-fold, respectively). Both mcti~holitcs showed ;III inverse relation t o the pli~smir cohalamin Icvcl. The very low cobalamin content of the miicrohiotic diet and low pl;lsniir cobalamin in milcrobiotic inl'ilnts m;~kcs ;in inip;~ircd coh;llamin function likely in thcsc infants. Wc thcrclorc uscd dictary group os ;In indcpcndcnt indicator of coh;llamiri status. Different tcst pilrilnictcrs for cohalaniin st;~tus wcrc evaluated hy comparing their ahility t o discriniiri;rtc hetween the two dietary groups. Logistic rcgrcssion irnalysis showed that methylmalonic acid followed by total homo-T h e h u m a n requirement for cobalamin is usually c o ve r e d b y food of animal origin (I). Nutritional cob;llamin dcticiency may, however, develop in strict vcgct;lrians (1, 2). O f particular c o n c e r n a r e several reports o n s c v c r c cobalamin deticiency in infants born t o vegetarian mothe r s (2-6). Neurologic disorders h a v c h c c n o b s e r v e d in s u c h infants (7) .
Megaloblastic a n e m i a a n d low s e r u m cobalamin have long b e e n considered t h e mainstay in the diagnosis of cystcinc and cohalamin, in that order, were the strongest predictors of dietary group. Mean corpuscular volunic and Ilh h;ld low discriminirtivc power. We concluilc thi~t the dctcrrniriation of nictliylniirlonic i~cid ;1nc1 tot;11 h o~i~o c y~t c i n c rcprcscnts ;I sensitive ;in11 spccilic tcst for the diirgnosis and lidlow-up ol' nutritionirl coh;ll;lmin ilclicicncy in inklrlts. Furthcrmorc, the linding o f high nicthylnii~lonic acid irnd total honit~ystcine in pli~sni;i of niost nl;~crohiotic infants demonstrates ;I functiori;~l cohi~l;~niiri dclicicncy irl thcsc suhjccts. Sup,,orted hy gritnth irtlnl the NO^^^^;^^^ Hrhc;lrCll ~~O l l l l r l~. ~~,~, l~~ ~I 1 h , I~I I 1 dl1 ring . impsired cobalaniin function h n v c t w c n dcvcl-Methionine synthase (EC 2.1.1.13), which remethylates Hcy to methionine, and methylmalonyl-CoA mutase (EC 5.4.99.2), which converts methylmalonyl-CoA to succinyl-CoA, are the only known mammalian enzymes requiring cobalamin as cofactor (14) . Inhibition of metabolic flux through these pathways and the resulting increase in the extracellular levels of MMA and Hcy reflect impaired intracellular cobalamin function. This explains the marked elevation of MMA and Hcy in plasma and urine from cobalamin-deficient patients (10, (15) (16) (17) . MMA seems to be a relatively sensitive and specific marker of cobalamin function, whereas Hcy also increases in folate-deficient patients (10) . Determination of MMA and Hcy in plasma and serum has been established as a valuable adjunct to the conventional laboratory tests for cobalamin deficiency, especially in cases with subtle or atypical symptoms. Additional attractive features are the relation between elevated metabolite level and therapeutic response and the possibility within 4 to 10 d to demonstrate the effect from supplementing the deficient vitamin by monitoring a decline in metabolite concentration (10, 17) .
There are occasional reports on marked elevation of urinary MMA (2, 7, 18, 19) and homocystine (2, 7, 18, 19) in cobalamin-deficient infants of vegetarian mothers, suggesting impairment of intracellular cobalamin function in these patients. Since 1985, techniques for the determination of these metabolites in serum and plasma have been developed and reference levels have been established in adults (20) (21) (22) (23) (24) . However, there are no data on MMA and Hcy in plasma or serum from healthy or diseased newborns or infants.
In a recent study, the cobalamin and hematologic status was investigated in infants on macrobiotic diets and group-matched omnivorous controls. The macrobiotic infants had very low cobalamin intake (25) and low plasma cobalamin levels combined with several hematologic abnormalities (6) . In the present paper, we report on the plasma levels of MMA and Hcy in these macrobiotic infants and in controls. The purpose of this study was 1 ) to obtain the normal levels of these metabolites in healthy infants; 2) to investigate the metabolite levels and thereby the intracellular cobalamin function in macrobiotic infants; and 3 ) to evaluate the usefulness of MMA and Hcy in plasma for the individual diagnosis of cobalamin deficiency in infancy.
METHODS

Subjects.
The subjects included in this study have been characterized in detail in a previous publication on nutritional status in macrobiotic infants (25) . Briefly, blood samples were taken from 50 such infants (26 boys) and 57 group-matched controls (31 boys) (6) . The mothers of the macrobiotic infants had lived on a diet described by Kushi and Jack (26) for at least 3 y and had been feeding their children breast milk from birth onward with later complementary feeding according to macrobiotic principles. Plasma samples for measurement of both MMA and total Hcy were available from 41 macrobiotic infants (22 boys) and 50 controls (27 boys). MMA was measured in an additional three samples from macrobiotic infants and four samples from control infants. The mean age of the macrobiotic infants was 16.8 mo (range 11.4-21.9 mo), and that of the controls was 15.8 mo (range 11.1-21.4 mo). Details on food consumption and the study design have been published (25) .
Blood sampling and storage. The macrobiotic and control infants were visited at home. Therefore, immediate preparation of the plasma fraction was impossible. Care was taken to visit macrobiotic and control infants in a randomized order. In this way, a systematic difference in time elapsing before centrifugation of whole blood was avoided.
The fasting period was 1 to 4 h in about 70% of the children. Blood samples of 4-5 mL were collected into heparinized glass tubes by venipuncture, carefully mixed, then immediately placed in a cooling box at 4-8"C, and later stored overnight at 4°C in a refrigerator before removal of the blood cells by centrifugation the next day.
The plasma samples were stored at -20°C for about 1.5 mo, then at -80°C for 5 y, and finally at -45°C for 6 mo. There is evidence that storage of frozen plasma at -20°C for up to 10 y does not change the plasma Hcy level (27).
Analytical methods. All parameters for each infant were assayed in samples collected at the same time point. MMA in plasma was assayed by a method based on HPLC and fluorescence detection; the coefficient of variation of this method is 3-1 1 % (23, 28) . Total plasma Hcy and cysteine were determined by a modification (29) of an automated procedure developed for the determination of total Hcy in plasma (30) ; the coefficient of variation of this method is <3% (29) . Plasma methionine was determined in deproteinized plasma with an assay based on derivatization with o-phthaldialdehyde and fluorescence detection (31) . The data for plasma cobalamin, plasma folate, Hb, and MCV are taken from the study of Dagnelie et al. (6) .
Statistical analysis. GM and GM 5 1.96 SD intervals were calculated for MMA, Hcy, cobalamin, methionine, and cysteine in the controls. Because of skew distribution, log-transformation of data was performed before calculation. The data were normally distributed after transformation, as judged by normal probability plots (data not shown). Group GM were compared with the two-sample r test. Correlation between parameters was determined using the r,.
In the controls, the 95th percentile for MMA and total Hcy and the 5th percentile for plasma cobalamin were calculated on the basis of the log-transformed data. The 95th percentile for MCV and 5th percentile for Hb were calculated from the nontransformed data. These values were defined as cutoff values. Metabolite concentrations or MCV above or cobalamin and Hb levels below the cutoff were regarded as abnormal.
Logistic regression analysis was used to predict the di-7.6 kmol/L (5.3-11.0 kmol/L) ( Table 1) . Neither plasma etary status (macrobiotic or control). MMA, Hcy, cobal-MMA nor total plasma Hcy was significantly related to amin, MCV, and Hb served as candidate predictor vari-the age of the infants. Methionine in plasma [6.9 (1.1-ables. The ability of the different tests, used alone or in 41.9) Fmol/L] was slightly lower than reported for chilcombination7 to predict dieta~y group was estimated by dren with a mean age of 8 y (32) . These values and the OR-Two-sidedP values less than 0.05 were considered ulasmaconcentrationsfortotalcysteineandcobalaminin significant.
control infants are summarized in Table 1 MMA, total Hcy, and methionine in plasma from healthy < 0.0001). The GM for total Hcy of 13.5 (6.8-26.8) control infants showed skew distribution. The GM for kmol/L was increased about 2-fold compared with con-MMA in 50 infants was 0.18 kmol/L (GM -t 1.96 SD, trols (p = 0.0014; Table 1 , Fig. 1 ). The plasma level of 0.06-0.51 kmol/L). The GM (n = 50) for total Hcy was methionine was not significantly different between mac- Table 1 . Plasma levels of metabolites and cobalamin in macrobiotic and healthy control infants* robiotic infants and controls. Total cysteine was slightly but significantly (p = 0.0001) reduced in macrobiotic infants (Table 1) . Relation between plasma metabolite concentrations and other parameters. MMA in plasma was inversely correlated (r, = -0.765, p < 0.001) with plasma cobalamin. A plot of cobalamin versus MMA gave a hyperbolic relation, and marked elevation of MMA was observed at levels of plasma cobalamin below about 220 pmol/L (Fig. 2) . Also, total Hcy showed an inverse correlation (r, = -0 . 7 4 1 ;~ < 0.001) with plasma cobalamin (Fig. 2) . The inverse correlation between MCV and plasma cobalamin, published previously (6), was weaker (r, = -0.313; p < 0.01). There was a strong positive correlation (r, = 0.772; p < 0.001) between MMA and total Hcy in plasma (Fig. 3 ), but in a few cases, only MMA (six cases) or total Hcy (seven cases) was elevated (Fig. 3) . Plasma folate was higher in the macrobiotic group than in the control group (6) and there was a tendency that high plasma folate levels were associated with high concentrations of total plasma Hcy in macrobiotic infants (r = 0.252; p = 0.1), but not in controls (r = -0.207; p = 0.15) (Fig. 4) . However, these relations were not statistically significant.
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Discriminationbe~eenmcrobioticinfantsandcontrols. M M A a s a t e s t topredict themacrobioticgroupwas35
In 91 infants, values were obtained for MMA, Hcy, and of 41 (85.4%). The corresponding values for Hcy and cobalamin; 41 infants belonged to the macrobiotic cobalamin were 34 of 41 (83%) and 34 of 41 (83%), group and 50 infants were controls. In 26 subjects, all respectively (Fig. I , Table 2 ). The simultaneous use of macrobiotic infants, all three parameters were abnor-MMA and Hcy (one or more positive), increases the mal. In another 13 macrobiotic and two control infants, sensitivity to 98% without loss of specificity (92%) two parameters were abnormal. The sensitivity of (Fig. 3) . Total homocysteine (pmol/L) Logistic regression was used to predict the dietary group from the values of MMA, total Hcy, cobalamin, MCV, and Hb. The single strongest predictor of dietary group was MMA with an OR of 140 (95% CI = 26.1-752). This means that the odds of belonging to the macrobiotic diet group were 140 times higher with an abnormal compared with a normal plasma MMA level. Total Hcy and cobalamin were also strong predictors, whereas MCV and Hb discriminated poorly between the diet groups (Table 3) .
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When all five parameters were included in the regression analysis simultaneously (multivariate analysis), again plasma MMA (OR = 109; 95% CI = 7.&1720) was superior to total Hcy (OR = 51.3; 95% CI = 2.1-1290) and plasma cobalamin (OR = 3.5; 95% CI = 0.25-50.8) as a predictor.
We also compared the ability of plasma MMA, total Hcy, MCV, and H b to increase the discriminative power afforded by plasma cobalamin (bivariate analysis). MMA had a higher OR (72.2; 95% CI = 9.07-575) than plasma Hcy (22.2; 95% CI = 3.34-147). The corresponding OR for MCV and Hb were 3.21 (95% CI = 0.38-27.1) and Table 2 were included in the analysis.
t Only one parameter is included in the analysis.
$ All parameters are included simultaneously. Q Cobalamin and one additional parameter are included.
11 p values > 0.05 were regarded a s not significant.
Blood sampling and reference values.
For organizational reasons, the whole-blood samples were stored overnight in a refrigerator (4°C) before centrifugation the next day. The time before blood cells were removed was maximally 24 h. It is unlikely that this affected the concentration of MMA in plasma, because even storage of whole blood for 24 h at room temperature has been shown to be without effect (33) . This is corroborated by the observation that the reference interval obtained for the healthy control infants in this study [0.06-0.51 (GM + 1.96 SD) kmol/L] equals that established for adults (20) (21) (22) (23) .
In whole blood, there is a time-and temperaturedependent production of Hcy. The amounts are independent of the plasma Hcy concentration (29) . The relative increase upon storage is therefore larger at low than at high Hcy concentrations. Based on data on Hcy production in whole blood from adults (29) , one might expect an artificial increase of about 1 pmol/L during storage for 24 h at 4-8°C. However, the increase in Hcy is limited, because the values for total Hcy in infants aged 10-24 mo obtained in the present study (GM 7.59 bmol/L) are of the same magnitude as the plasma concentrations previously reported in 10 children aged 6.2 + 3.5 y (34) and are lower than the normal level published for adults (35) .
In studies based on stored samples, blood sampling and processing often do not fully comply with the strict procedures recommended for the determination of Hcy (24) . In general, a moderate increase in plasma Hey occurring before separation of blood cells does not undermine the diagnostic value of plasma Hcy as an indicator of vitamin deficiency, inasmuch as these conditions induce a marked elevation of the plasma Hcy level (24) . In casecontrol studies, such error is partly adjusted for by identical sample handling for the investigated population and the reference group. This was accomplished in the present study. Furthermore, the variability in plasma Hcy among the 50 control infants (95% CI = 5.3-11.0 pmol/L; Table 1 ) is less than the variability of plasma Hcy in 3000 healthy men sampled under optimal conditions (24) . This strongly suggests a uniform procedure for sample handling in the present study. The limited increase in plasma Hcy that probably takes place before the removal of the blood cells would reduce the relative difference in plasma Hcy between macrobiotic infants and controls. This results in an underestimation of the diagnostic sensitivity and specificity of plasma Hcy.
Cobalamin function and metabolite response in macrobiotic infants. The hematologic parameters showed subtle differences between macrobiotic infants and controls, and there was considerable overlap between the groups. Hb was not significantly different between the groups. Hematocrit and red blood cell count were lower, and MCV, mean corpuscular Hb, and mean corpuscular Hb concentration were higher in macrobiotic infants compared with controls. No significant neurologic dysfunction could be demonstrated upon clinical examination, but the macrobiotic children showed retardation of growth and psychomotor development compared with the omnivorous controls (36) . Plasma cobalamin was markedly reduced in macrobiotic infants, suggesting impaired cobalamin function in most macrobiotic infants.
In adults, M M A in serum and plasma is a more specific marker for cobalamin function than total Hcy, which is also elevated in folate-deficient patients and in some other diseases (24) . M M A also seems to have a somewhat higher sensitivity than total Hcy (10). Of particular importance is the finding of elevated serum M M A or total Hcy in 94% of patients with an objective biochemical response to cobalamin supplementation ( 1 1). In another study on clinically confirmed cobalamin-deficient patients, a test sensitivity of 97% and a specificity of 91% were reported for serum M M A (37) .
Plasma and serum levels of M M A and total Hcy probably reflect intracellular cobalamin function in infants in the same way as in adults. This is supported by the observed relation between plasma cobalamin and metabolite concentrations, as depicted in Figure 2 . Elevation of M M A , total Hcy, or both in plasma (Fig. 3) is observed in 40 of 41 macrobiotic infants (Table 2 ). This finding shows that low plasma cobalamin is associated with impaired cobalamin function in a much larger portion of these infants than might be expected from the occurrence of hematologic abnormalities (6) .
It has been shown previously that plasma folate levels in the macrobiotic infants were markedly elevated and negatively related to plasma cobalamin. Regression analysis suggested that the deleterious effect of low plasma cobalamin on hematologic parameters was stronger at high folate concentrations. Thus, the high folate in macrobiotic infants is probably not caused by high folate intake but is a consequence of cobalamin deficiency (6) . Our data, which show a positive (although not statistically significant) relation between plasma folate and total Hcy in macrobiotic infants (Fig. 4) , are in contrast to the negative correlation between these two parameters found in a population of adults with variable folate status (24) . This indicates impaired tissue utilization of folate during cobalamin deficiency. Elevation of both folate and total Hcy in plasma may reflect an impaired function of the cobalamin-dependent methionine synthase resulting in accumulation of the substrates, Hcy. and 5-methyltetrahydrofolate.
Evaluation of MMA and total Hcy in plasma as diagnostic tests. To evaluate plasma M M A and total plasma Hcy as tests to reveal cobalamin deficiency in individual infants, an objective measure of functional cobalamin deficiency is required. Clinical improvement andlor normalization of metabolite concentrations after cobalamin supplementation may be regarded as independent measures of cobalamin deficiency (11, 37). However, the clinical and hematologic symptoms are often subtle. and an intervention was performed in only a limited number of infants included in the present study (38, 39) . Therefore, our data do not allow an independent discrimination between healthy and cobalamin-deficient infants.
Because no clinical sign or independent biochemical test discriminates between cobalamin-deficient and healthy infants, we chose dietary group as an independent indicator of cobalamin deficiency in these infants, assuming that cobalamin-deficient and nondeficient infants coincide with the macrobiotic group and control group, respectively. To our best knowledge there do not exists reports on nutritional cobalamin deficiency in infants born to healthy omnivorous mothers, suggesting that this is extremely rare. In contrast, based on analytical data of plant foods included in the macrobiotic diet, thc estimated cobalamin intake in these infants is extremely low (25) . Furthermore, elevated M C V was previously reported in the macrobiotic group (6). Importantly, the rise in M C V was not limited to just a few macrobiotic infants, but the macrobiotic group as a whole showed an elevation of M C V resulting in a shift of the cumulative frequency curve of M C V toward higher values compared with the control group. This supports the view that (even though M C V values were apparently within "normal" range for part of the macrobiotic group) the macrobiotic group as a whole is a cobalamin-deficient population. These considerations justify the assumption that group membership (i.cj. macrobiotic versus omnivorous group) is a good indicator of cobalamin deficiency tvc.rsus no deficiency.
MMA, total Hcy and cobalamin measurements identified the macrobiotic infants with high sensitivity (>82%) ( Table 7) , but regression analyses showed that plasma M M A had the highest discriminative power followed closely by total plasma Hcy and plasma cobalamin, both when analyzed separately (univariate analysis) and simultaneously (multivariate analysis). M C V and, even more so, Hb were insensitive and unspecific in diagnosing cobalamin deficiency in the individual infant (Table  3) , even though M C V was useful as an indicator of cobalamin deficiency in a population (6) . We also evaluated which test added the most information when cobalamin value was already included in the predictive equation (bivariate analysis), and M M A was also superior in this respect (Table 3) .
The OR for elevated M M A and total Hcy were different, and M M A , Hcy, and cobalamin provide independent predictive information (Table 3) . This is related to the observation that in some macrobiotic infants, the plasma level of only one metabolite is elevated, as demonstrated in Figure 3 . Thus, determination of the plasma levels of both M M A and total Hcy may discriminate better between the groups than one parameter alone, and the simultaneous use of M M A and Hcy increases the test sensitivity without loss of specificity (sensitivity 98%; specificity 92%).
Plasma M M A , in contrast to total Hcy, is a specific marker of cobalamin function (lo), but adding total Hcy to the test battery may differentiate nutritional cobalamin deficiency from "benign" methylmalonic aciduria (40) or some rare congenital cobalamin mutations affecting methylmalonyl CoA mutase (I).
Conclusion. The marked elevation of both plasma MMA and total Hcy in macrobiotic infants compared with controls presents further evidence in favor of a functional cobalamin deficiency in a vast majority of these infants. Determination of metabolite concentrations in plasma and serum discriminates most cobalamindeficient infants from healthy controls and represents a useful adjunct to the conventional diagnostic tests. The analysis can be carried out in samples already collected for the cobalamin assay, and no urine collection or determination of creatinine is required. Finally, normalization of metabolite levels in plasma is an objective and early measure of therapeutic response. These are features of importance for a rapid diagnosis as well as for a close follow-up of nutritional cobalamin deficiency in infants.
